Clinical studies recruiting near Bellflower

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Clinical Innovations, Inc. dba CITrials · Bristol-Myers Squibb · NCT06929273 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-Bellflower · NRG Oncology · NCT05174169 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Kaiser Permanente-Bellflower · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Kaiser Permanente-Bellflower · Canadian Cancer Trials Group · NCT06592924 Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07484217 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente-Bellflower · NRG Oncology · NCT06748222 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Kaiser Permanente-Bellflower · NRG Oncology · NCT03180268 A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · Clinical Innovations, Inc. dba CITrials · Bristol-Myers Squibb · NCT07140913 Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Phase 3 · Kaiser Permanente-Bellflower · Children's Oncology Group · NCT05235165 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Kaiser Permanente-Bellflower · NRG Oncology · NCT04852887 A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Phase 4 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06223880 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Kaiser Permanente-Bellflower · NRG Oncology · NCT05080673 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Kaiser Permanente-Bellflower · National Cancer Institute (NCI) · NCT05987241 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Kaiser Permanente-Bellflower · SWOG Cancer Research Network · NCT04205968 A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acu
Phase 2 · Kaiser Permanente-Bellflower · National Cancer Institute (NCI) · NCT04546399 A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · Clinical Innovations, Inc. dba CITrials (Bellflower) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Kaiser Permanente-Bellflower · SWOG Cancer Research Network · NCT06616584 Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Sympt
Phase 3 · Clinical Innovations, Inc. dba CITrials · Minerva Neurosciences · NCT07565428 Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
Phase 2 · CenExel · LB Pharmaceuticals Inc. · NCT07494305 A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Phase 2 · Southern California Permanente Medical Group · Mirati Therapeutics Inc. · NCT07415031 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Kaiser Permanente-Bellflower · SWOG Cancer Research Network · NCT03723928 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Phase 3 · Clinical Innovations Inc · Xenon Pharmaceuticals Inc. · NCT07076407 "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Phase 3 · CenExel CIT (Clinical Innovations, Inc) · Cybin IRL Limited · NCT06564818 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Kaiser Permanente-Bellflower · National Cancer Institute (NCI) · NCT04267848 A Study to Evaluate the Effect of KarXT on Urological Safety
Phase 4 · Clinical Innovations, Inc. dba CITrials · Bristol-Myers Squibb · NCT07221877 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Kaiser Permanente-Bellflower · SWOG Cancer Research Network · NCT03851445 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · Kaiser Permanente-Bellflower · National Cancer Institute (NCI) · NCT07061977 A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipola
Phase 3 · Clinical Innovations Inc · Xenon Pharmaceuticals Inc. · NCT07172516 Study of ALTO-300 in MDD
Phase 2 · Site 218 · Alto Neuroscience · NCT05922878 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · Kaiser Permanente-Bellflower · NRG Oncology · NCT06580314

Look up another city

Look up another condition